Cargando…
P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428392/ http://dx.doi.org/10.1097/01.HS9.0000968448.07133.3e |
| _version_ | 1785090458091782144 |
|---|---|
| author | Agustina Perusini, Maria Gupta, Vikas Bankar, Aniket Sibai, Jad Minden, Mark Maze, Dawn Davidson, Marta Richard-Carpentier, Guillaume M Chan, Steven Schuh, Andre Yee, Karen Atenafu, Eshetu Sibai, Hassan |
| author_facet | Agustina Perusini, Maria Gupta, Vikas Bankar, Aniket Sibai, Jad Minden, Mark Maze, Dawn Davidson, Marta Richard-Carpentier, Guillaume M Chan, Steven Schuh, Andre Yee, Karen Atenafu, Eshetu Sibai, Hassan |
| author_sort | Agustina Perusini, Maria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428392 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104283922023-08-17 P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE Agustina Perusini, Maria Gupta, Vikas Bankar, Aniket Sibai, Jad Minden, Mark Maze, Dawn Davidson, Marta Richard-Carpentier, Guillaume M Chan, Steven Schuh, Andre Yee, Karen Atenafu, Eshetu Sibai, Hassan Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428392/ http://dx.doi.org/10.1097/01.HS9.0000968448.07133.3e Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Agustina Perusini, Maria Gupta, Vikas Bankar, Aniket Sibai, Jad Minden, Mark Maze, Dawn Davidson, Marta Richard-Carpentier, Guillaume M Chan, Steven Schuh, Andre Yee, Karen Atenafu, Eshetu Sibai, Hassan P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE |
| title | P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE |
| title_full | P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE |
| title_fullStr | P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE |
| title_full_unstemmed | P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE |
| title_short | P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE |
| title_sort | p385: comparison of clinical outcomes and adverse events in older adults with acute lymphoblastic leukemia treated with native vs pegylated asparaginase |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428392/ http://dx.doi.org/10.1097/01.HS9.0000968448.07133.3e |
| work_keys_str_mv | AT agustinaperusinimaria p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase AT guptavikas p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase AT bankaraniket p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase AT sibaijad p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase AT mindenmark p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase AT mazedawn p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase AT davidsonmarta p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase AT richardcarpentierguillaume p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase AT mchansteven p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase AT schuhandre p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase AT yeekaren p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase AT atenafueshetu p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase AT sibaihassan p385comparisonofclinicaloutcomesandadverseeventsinolderadultswithacutelymphoblasticleukemiatreatedwithnativevspegylatedasparaginase |